Correlations of Breast Carcinoma Biomarkers and p53 Tested by FASAY and Immunohistochemistry

Author： Vagunda Václav Šmardová Jana Vagundová Marcela Jandáková Eva Žaloudík Jan Koukalová Hana

ISSN： 0344-0338

Source： Pathology Research and Practice, Vol.199, Iss.12, 2004-01, pp. : 795-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thyroid Carcinoma Is Characterized by Genomic Instability: Evidence from p53 Mutations

By Shahedian B. Shi Y. Zou M. Farid N.R.

Molecular Genetics and Metabolism, Vol. 72, Iss. 2, 2001-02 ,pp. : 155-163

Academic Press

Access to resources Recommend Favorite

A Comparison Between -Fetoprotein and P53 Antibodies in the Diagnosis of Hepatocellular Carcinoma

By Edis C. Kahler C. Klotz W. Herold M. Feichtinger H. Konigsreiner A. Margreiter R. Jaschke W. Vogel W.

Transplantation Proceedings, Vol. 30, Iss. 3, 1998-05 ,pp. : 780-781

Elsevier

Access to resources Recommend Favorite

P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast

By Paredes Joana Milanezi Fernanda Viegas Leda Amendoeira Isabel Schmitt Fernando

Virchows Archiv, Vol. 440, Iss. 1, 2002-01 ,pp. : 16-21

Springer Publishing Company

Access to resources Recommend Favorite

Gene Therapy with P53 and a Fragment of Thrombospondin I Inhibits Human Breast Cancer in Vivo

By Xu M. Kumar D. Stass S.A. Mixson A.J.

Molecular Genetics and Metabolism, Vol. 63, Iss. 2, 1998-02 ,pp. : 103-109

Academic Press

Access to resources Recommend Favorite

Expression of Topoisomerase II Alpha, ki67, and p53 in Primary Non-Muscle-Invasive Urothelial Bladder Carcinoma

Journal of Immunoassay and Immunochemistry, Vol. 35, Iss. 4, 2014-10 ,pp. : 358-367

Taylor & Francis Ltd

Access to resources Recommend Favorite